1. Home
  2. LGND vs OTTR Comparison

LGND vs OTTR Comparison

Compare LGND & OTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • OTTR
  • Stock Information
  • Founded
  • LGND 1987
  • OTTR 1907
  • Country
  • LGND United States
  • OTTR United States
  • Employees
  • LGND 68
  • OTTR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • OTTR Electric Utilities: Central
  • Sector
  • LGND Health Care
  • OTTR Utilities
  • Exchange
  • LGND Nasdaq
  • OTTR Nasdaq
  • Market Cap
  • LGND 3.2B
  • OTTR 3.5B
  • IPO Year
  • LGND 1992
  • OTTR N/A
  • Fundamental
  • Price
  • LGND $169.53
  • OTTR $83.82
  • Analyst Decision
  • LGND Strong Buy
  • OTTR
  • Analyst Count
  • LGND 8
  • OTTR 0
  • Target Price
  • LGND $144.71
  • OTTR N/A
  • AVG Volume (30 Days)
  • LGND 139.7K
  • OTTR 154.4K
  • Earning Date
  • LGND 08-05-2025
  • OTTR 11-03-2025
  • Dividend Yield
  • LGND N/A
  • OTTR 2.52%
  • EPS Growth
  • LGND N/A
  • OTTR N/A
  • EPS
  • LGND N/A
  • OTTR 6.79
  • Revenue
  • LGND $181,488,000.00
  • OTTR $1,311,540,000.00
  • Revenue This Year
  • LGND $18.41
  • OTTR $0.94
  • Revenue Next Year
  • LGND $18.87
  • OTTR $4.69
  • P/E Ratio
  • LGND N/A
  • OTTR $12.26
  • Revenue Growth
  • LGND 53.40
  • OTTR N/A
  • 52 Week Low
  • LGND $81.74
  • OTTR $71.66
  • 52 Week High
  • LGND $129.90
  • OTTR $88.36
  • Technical
  • Relative Strength Index (RSI)
  • LGND 72.58
  • OTTR 55.14
  • Support Level
  • LGND $161.82
  • OTTR $82.57
  • Resistance Level
  • LGND $169.00
  • OTTR $84.75
  • Average True Range (ATR)
  • LGND 3.90
  • OTTR 1.32
  • MACD
  • LGND -0.81
  • OTTR -0.24
  • Stochastic Oscillator
  • LGND 98.73
  • OTTR 51.52

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About OTTR Otter Tail Corporation

Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.

Share on Social Networks: